Free Trial

China SXT Pharmaceuticals (NASDAQ:SXTC) Stock Price Down 1.3% - Here's What Happened

China SXT Pharmaceuticals logo with Medical background

Key Points

  • Shares of China SXT Pharmaceuticals (NASDAQ:SXTC) fell by 1.3%, trading at $1.54 after hitting a low of $1.50 during the session.
  • The stock's trading volume increased by 30% to 84,835 shares compared to its average volume of 65,272 shares.
  • China SXT Pharmaceuticals specializes in the research, development, manufacture, and sale of traditional Chinese medicine products in China.
  • MarketBeat previews top five stocks to own in September.

China SXT Pharmaceuticals, Inc. (NASDAQ:SXTC - Get Free Report)'s stock price was down 1.3% on Tuesday . The stock traded as low as $1.50 and last traded at $1.54. Approximately 84,835 shares traded hands during trading, an increase of 30% from the average daily volume of 65,272 shares. The stock had previously closed at $1.56.

China SXT Pharmaceuticals Trading Up 9.0%

The company has a fifty day moving average of $1.70 and a two-hundred day moving average of $2.45.

China SXT Pharmaceuticals Company Profile

(Get Free Report)

China SXT Pharmaceuticals, Inc, a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine pieces (TCMP) in China. The company offers advanced, fine, and regular TCMP products, and raw medicinal material, such as ChenXiang, SanQiFen, HongQi, SuMu, JiangXiang, CuYanHuSuo, XiaTianWu, LuXueJing, XueJie, ChaoSuanZaoRen, HongQuMi, ChuanBeiMu, HuangShuKuiHua, WuWeiZi, DingXiang, RenShen, QingGuo, JueMingZi, and ShaRen.

Recommended Stories

Should You Invest $1,000 in China SXT Pharmaceuticals Right Now?

Before you consider China SXT Pharmaceuticals, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and China SXT Pharmaceuticals wasn't on the list.

While China SXT Pharmaceuticals currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Energy Stocks to Buy and Hold Forever Cover

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

5 Stocks to BUY NOW in August 2025
The $2.5B Merger No One Is Talking About
ALERT: Big Tech Earnings – Watch Before Wednesday

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines